Further, GnRH-a treatment combined with high-intensity focused ultrasound ablation has been found to reduce serum CA125, attenuate adenomyosis lesions, and reduce menstrual blood volume and dysmenorrhea [21]. Here, GNRH1 is linked to adenomyosis.